Literature DB >> 25627976

miR340 suppresses the stem-like cell function of glioma-initiating cells by targeting tissue plasminogen activator.

Daisuke Yamashita1, Toru Kondo2, Shiro Ohue3, Hisaaki Takahashi4, Madoka Ishikawa5, Ryo Matoba5, Satoshi Suehiro6, Shohei Kohno6, Hironobu Harada6, Junya Tanaka4, Takanori Ohnishi6.   

Abstract

Glioma-initiating cells (GIC) have stem-like cell properties thought to be sufficient for recurrence, progression, and drug resistance in glioblastomas. In the present study, we defined miRNA (miR)-340 as a differentially expressed miRNA in human GICs that inhibit GIC-mediated tumorigenesis. Furthermore, we defined tissue plasminogen activator (PLAT) as a critical direct target of miR340 for inhibition. Among miRNAs screened, we found that miR340 expression was decreased in all human GICs and in human glioblastoma tissues, compared with human neural stem cells and normal brain tissues. miR340 overexpression in GICs suppressed their proliferative, invasive, and migratory properties in vitro, triggering cell senescence in vitro and inhibiting GIC-induced tumorigenesis in mouse brains. shRNA-mediated silencing of PLAT in GICs phenocopied the effects of miR340 overexpression in vitro and in vivo, suggesting a potential role for tissue factor in stem-like cell function. Taken together, our results identified miR340 as a tumor suppressor that functions in GIC to enforce PLAT blockade and ablate their stem-like functions. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25627976     DOI: 10.1158/0008-5472.CAN-14-0938

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  22 in total

1.  An miR-340-5p-macrophage feedback loop modulates the progression and tumor microenvironment of glioblastoma multiforme.

Authors:  Yunyun Liu; Xiaoyu Li; Yuanpei Zhang; Hongxuan Wang; Xiongming Rong; Jialing Peng; Lei He; Ying Peng
Journal:  Oncogene       Date:  2019-08-19       Impact factor: 9.867

2.  Large-scale assessment of the gliomasphere model system.

Authors:  Dan R Laks; Thomas J Crisman; Michelle Y S Shih; Jack Mottahedeh; Fuying Gao; Jantzen Sperry; Matthew C Garrett; William H Yong; Timothy F Cloughesy; Linda M Liau; Albert Lai; Giovanni Coppola; Harley I Kornblum
Journal:  Neuro Oncol       Date:  2016-04-25       Impact factor: 12.300

3.  LncRNA RUSC1-AS1 contributes to the progression of hepatocellular carcinoma cells by modulating miR-340-5p/CREB1 axis.

Authors:  Chunjiang Liu; Liming Tang; Miaojun Xu; Yuting Lin; Jingfu Shen; Liang Zhou; Lichen Ho; Jinjing Lu; Xiaoming Ai
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

4.  MicroRNA-183 promotes migration and invasion of CD133(+)/CD326(+) lung adenocarcinoma initiating cells via PTPN4 inhibition.

Authors:  Conghui Zhu; Xi Deng; Jingbo Wu; Jianwen Zhang; Hongru Yang; Shaozhi Fu; Yan Zhang; Yunwei Han; Yuanmei Zou; Zhengtang Chen; Sheng Lin
Journal:  Tumour Biol       Date:  2016-03-07

5.  MiR-340 Regulates Fibrinolysis and Axon Regrowth Following Sciatic Nerve Injury.

Authors:  Shiying Li; Ruirui Zhang; Ying Yuan; Sheng Yi; Qianqian Chen; Leilei Gong; Jie Liu; Fei Ding; Zheng Cao; Xiaosong Gu
Journal:  Mol Neurobiol       Date:  2016-06-25       Impact factor: 5.590

Review 6.  microRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessment.

Authors:  Igor Koturbash; William H Tolleson; Lei Guo; Dianke Yu; Si Chen; Huixiao Hong; William Mattes; Baitang Ning
Journal:  Biomark Med       Date:  2015-10-26       Impact factor: 2.851

7.  Decreased Expression of MiRNA-204-5p Contributes to Glioma Progression and Promotes Glioma Cell Growth, Migration and Invasion.

Authors:  Zhiqiang Xia; Fang Liu; Jian Zhang; Li Liu
Journal:  PLoS One       Date:  2015-07-02       Impact factor: 3.240

8.  miR-340 predicts glioblastoma survival and modulates key cancer hallmarks through down-regulation of NRAS.

Authors:  Danilo Fiore; Elvira Donnarumma; Giuseppina Roscigno; Margherita Iaboni; Valentina Russo; Alessandra Affinito; Assunta Adamo; Fabio De Martino; Cristina Quintavalle; Giulia Romano; Adelaide Greco; Ylermi Soini; Arturo Brunetti; Carlo M Croce; Gerolama Condorelli
Journal:  Oncotarget       Date:  2016-04-12

9.  miR-101 inhibits glioma cell invasion via the downregulation of COX-2.

Authors:  Chunyang Ma; Chuanyi Zheng; Enqi Bai; Kun Yang
Journal:  Oncol Lett       Date:  2016-08-03       Impact factor: 2.967

Review 10.  MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics.

Authors:  Amanda Shea; Varsha Harish; Zainab Afzal; Juliet Chijioke; Habib Kedir; Shahnoza Dusmatova; Arpita Roy; Malathi Ramalinga; Brent Harris; Jan Blancato; Mukesh Verma; Deepak Kumar
Journal:  Cancer Med       Date:  2016-06-10       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.